| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8747128 | Journal of Virological Methods | 2018 | 4 Pages |
Abstract
Advantages of HIV/HCV/HBsAg Triplex for HIV-1, HIV-2, HCV and HBV include the requirement for less overall specimen volume, fewer finger-sticks if capillary whole blood is used, cost savings through lower cost per virus tested, improved patient flow with results for multiple viruses available at the same time, overall service delivery efficiencies with less time required per infected patient; and patient benefits from fewer visits and lower cost associated with each clinic attendance. The screening of chronic HIV, HCV and HBV by multiplex HIV-1/HIV-2/HCV/HBsAg Triplex may improve the “cascade of screening” and quite possibly linkage-to-care with reduced cost.
Related Topics
Life Sciences
Immunology and Microbiology
Virology
Authors
Leman Robin, Ralph-Sydney Mboumba Bouassa, Zita Aleyo Nodjikouambaye, Laura Charmant, Mathieu Matta, Sylvie Simon, Mounir Filali, Souleymane Mboup, Laurent Bélec,